» Articles » PMID: 33407572

Association of Three Missense Mutations in the Homocysteine-related MTHFR and MTRR Gene with Risk of Polycystic Ovary Syndrome in Southern Chinese Women

Overview
Publisher Biomed Central
Date 2021 Jan 7
PMID 33407572
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The etiology between homocysteine and polycystic ovary syndrome (PCOS) is unclear. In humans, the level of homocysteine is mainly affected by two enzymes: methylene tetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR). While the activity of these two enzymes is mainly affected by three missense mutations, namely C677T (MTHFR), A1298C (MTHFR), and A66G (MTRR). This study aims to examine the association between the three missense mutations and PCOS and investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level.

Methods: A case-control study was designed, comprising 150 people with PCOS and 300 controls. Logistic regression analysis was used to assess the association between the three missense mutations and PCOS. Linear regression analysis was used to assess the association between the three missense mutations and the homocysteine level. Mediation analysis was used to investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level.

Results: Following adjustments and multiple rounds of testing, MTHFR A1298C was found to be significantly associated with PCOS in a dose-dependent manner (compared to AA, OR = 2.142 for AC & OR = 3.755 for CC; P < 0.001). MTRR A66G was nominally associated with PCOS. Mutations in MTHFR A1298C and MTRR A66G were significantly associated with the homocysteine level. Mediation analysis suggested the effect of MTHFR A1298C on PCOS was mediated by homocysteine.

Conclusions: MTHFR A1298C and MTRR A66G were associated with PCOS, and MTHFR A1298C might affect the risk of PCOS by influencing the homocysteine level.

Citing Articles

Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: A systematic review and meta-analysis.

Ulloque-Badaracco J, Al-Kassab-Cordova A, Hernandez-Bustamante E, Alarcon-Braga E, Cabrera-Guzman J, Horruitiner-Mendoza A Womens Health (Lond). 2024; 20:17455057241279039.

PMID: 39320480 PMC: 11437568. DOI: 10.1177/17455057241279039.


Discovery of a novel homocysteine thiolactone hydrolase and the catalytic activity of its natural variants.

Hou S, Liu H, Hu Y, Zhang J, Deng X, Li Z Protein Sci. 2024; 33(8):e5098.

PMID: 38980003 PMC: 11232049. DOI: 10.1002/pro.5098.


Folate and Vitamin B12 Levels in Chilean Women with PCOS and Their Association with Metabolic Outcomes.

Carrasco-Cabezas M, Assmann T, Martinez P, Cerpa L, Calfunao S, Echiburu B Nutrients. 2024; 16(12).

PMID: 38931291 PMC: 11206694. DOI: 10.3390/nu16121937.


Unraveling Extremely Damaging Variants and Their Potential Implications for IRAK4 Inhibitor Efficacy.

Behairy M, Eid R, Otifi H, Mohammed H, Alshehri M, Asiri A J Pers Med. 2023; 13(12).

PMID: 38138875 PMC: 10744719. DOI: 10.3390/jpm13121648.


Homocysteine Levels Are Associated With the Rupture of Intracranial Aneurysms.

Wei S, Yuan X, Li D, Guo X, Guan S, Xu Y Front Neurosci. 2022; 16:945537.

PMID: 35911998 PMC: 9330164. DOI: 10.3389/fnins.2022.945537.


References
1.
Yuan Y, Li J, Jing Z, Yu C, Zhao D, Hao W . The role of mental health and physical activity in the association between sleep quality and quality of life among rural elderly in China: A moderated mediation model. J Affect Disord. 2020; 273:462-467. DOI: 10.1016/j.jad.2020.05.093. View

2.
Fouani F, Fadaei R, Moradi N, Zandieh Z, Ansaripour S, Yekaninejad M . Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study. PLoS One. 2020; 15(4):e0231943. PMC: 7182262. DOI: 10.1371/journal.pone.0231943. View

3.
Kozakova M, Morizzo C, Penno G, Shore A, Nilsson J, Palombo C . Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors. J Clin Endocrinol Metab. 2020; 105(8). DOI: 10.1210/clinem/dgaa289. View

4.
Szafarowska M, Segiet A, Jerzak M . Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS. Neuro Endocrinol Lett. 2016; 37(2):141-6. View

5.
Merkin S, Phy J, Sites C, Yang D . Environmental determinants of polycystic ovary syndrome. Fertil Steril. 2016; 106(1):16-24. DOI: 10.1016/j.fertnstert.2016.05.011. View